The CEO of U.S.-based pharmaceutical and biotechnology company Moderna said he hopes for a booster shot for its two-dose COVID-19 vaccine to become available in the fall.
Stéphane Bancel made the announcement during an interview with CNBC’s “Squawk Box” on Wednesday, saying the company is working towards the booster shot in case it will be needed against emerging variants of the CCP (Chinese Communist Party) virus—which causes the disease COVID-19.
